Georgieva, M., Lund, J. L., Nielsen, M. E., Trogdon, J., Dinan, M. A., Weinberger, M., & Wheeler, S. B. (2018). The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer. In Value in Health (Vol. 21, pp. S141–S141). Elsevier BV. https://doi.org/10.1016/j.jval.2018.04.951

Georgieva, M., J. L. Lund, M. E. Nielsen, J. Trogdon, M. A. Dinan, M. Weinberger, and S. B. Wheeler. “The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer.” In Value in Health, 21:S141–S141. Elsevier BV, 2018. https://doi.org/10.1016/j.jval.2018.04.951.

Georgieva M, Lund JL, Nielsen ME, Trogdon J, Dinan MA, Weinberger M, et al. The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer. In: Value in Health. Elsevier BV; 2018. p. S141–S141.

Georgieva, M., et al. “The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer.” Value in Health, vol. 21, Elsevier BV, 2018, pp. S141–S141. Crossref, doi:10.1016/j.jval.2018.04.951.

Georgieva M, Lund JL, Nielsen ME, Trogdon J, Dinan MA, Weinberger M, Wheeler SB. The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer. Value in Health. Elsevier BV; 2018. p. S141–S141.